Question 1

What is Helmy Eltoukhy?

Accepted Answer

Helmy Eltoukhy is a Person.

Question 2

How often does Helmy Eltoukhy appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Helmy Eltoukhy first tracked by Ergen?

Accepted Answer

First tracked on Jun 11, 2026.

Question 4

When was Helmy Eltoukhy last mentioned in news?

Accepted Answer

Last active on Jun 11, 2026.

Question 5

What is Helmy Eltoukhy's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Helmy Eltoukhy in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Helmy Eltoukhy?

Accepted Answer

FDA approves Guardant360 CDx for HERNEXEOS (Jun 11, 2026, 7 articles).

Question 8

How did the "FDA approves Guardant360 CDx for HERNEXEOS" event impact Helmy Eltoukhy?

Accepted Answer

Helmy Eltoukhy, chairman and co-CEO of Guardant Health, commented on the significance of the FDA approval for Guardant360 CDx, highlighting its impact on advanced cancer care.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.